24 Questions
What is the main difference in the absorption rate of the two formulations discussed?
Formulation B has a slower rate of release.
What is the primary factor in determining the peak concentration and time to reach the MEC?
Rate of absorption.
What is the minimum effective concentration (MEC) in the context of pharmacokinetics?
The lowest concentration at which the drug is effective.
What does the area under the serum concentration-time curve (AUC) represent?
The total amount of drug absorbed into the circulation.
What is the main difference in the duration of action between formulations A and B?
Formulation B has a longer duration of action.
What is the primary factor in determining the bioavailability of a drug?
Rate of absorption.
What parameter represents the maximum concentration of the drug in the blood?
Cmax
What is the relationship between the peak concentration and the rate of absorption?
A faster rate of absorption results in a higher peak concentration.
What does a difference in AUC values between formulations indicate?
A difference in the extent of absorption.
What is the primary difference between formulations A and B?
Formulation B has a slower rate of release.
What is the AUC for formulation A?
34.4 µg/mL X hours.
What represents the total amount of the drug absorbed by the body?
AUC
What is the time it takes to reach the peak concentration of the drug in the blood?
Tmax
What does the Time of Peak (Tmax) reflect?
The rate of absorption of the drug from the formulation
What is the process of comparing the amount of the drug absorbed by the body from different formulations?
Bioavailability
What is the graph that shows the concentration of the drug in the blood over time?
Concentration-time curve
What is the primary goal of individual dosing of a patient?
To achieve the MEC but not the MTC
What is the minimum concentration of the drug required to produce a therapeutic effect?
Minimum Effective Concentration
What is the effect of increasing the dose size on the blood drug concentration-time curve?
The Cmax is proportionately higher and the AUC is proportionately greater
What is the difference between the two formulations A and B in terms of achieving the desired pharmacologic effect?
Formulation A achieves the MEC but formulation B does not
What is the relationship between the dose size and the Area Under the Curve (AUC)?
The AUC is directly proportional to the dose size
What is the effect of increasing the dose size on the Tmax?
The Tmax is unchanged
What is the role of bioavailability in achieving the desired pharmacologic effect?
It affects the rate of absorption of the drug from the formulation
What is the minimum concentration of the drug required to produce the desired pharmacologic effect?
Minimum Effective Concentration (MEC)
Study Notes
Serum Concentration-Time Curve
- Shows peak height concentrations, peak height times, times to reach Minimum Effective Concentration (MEC), and areas under the curves for equal amounts of drug from two different formulations following oral administration.
Formulations A and B
- Formulation A achieves the required blood levels of drug to produce the desired pharmacologic effect, whereas formulation B does not.
- If the MEC for the drug is 2.0 µg/mL and the Minimum Toxic Concentration (MTC) is 4.0 µg/mL, equal doses of the two formulations result in toxic effects produced by formulation A but only desired effects by formulation B.
Individual Dosing
- The objective is to achieve the MEC but not the MTC.
Effect of Dose Size on Blood Drug Concentration-Time Curves
- As the dose increases, the Cmax (peak height concentration) is proportionately higher and the AUC (area under the curve) proportionately greater.
- Tmax (time to reach Cmax) is the same for each dose.
Rate of Absorption
- Reflects the rate of absorption from a formulation, which determines the time needed to reach the MEC and thus initiate the desired effect.
- Influences the period over which the drug enters the bloodstream and affects the duration of the drug's presence in the blood.
Time of Peak
- Formulation A allows the drug to reach the MEC within 30 minutes following administration and a peak concentration in 1 hour.
- Formulation B has a slower rate of release, reaching the MEC 2 hours after administration and its peak concentration 4 hours after administration.
Comparative Evaluation of Bioavailability
- Important parameters to consider:
- Peak height concentration (Cmax)
- Time of the peak concentration (Tmax)
- Area under the blood concentration-time curve (AUC)
Peak Height
- Concentration-time curves showing different peak height concentrations for equal amounts of drug from two different formulations following oral administration.
Compare the serum concentration-time curves of two drug formulations, Formulation A and Formulation B, to determine their effectiveness in achieving desired blood levels and pharmacologic effects.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
